subject: Qrxpharma Limited (qrx) - Financial And Strategic Analysis Review --- Aarkstore Enterprise [print this page] QRxPharma Limited (QRX) - Financial and Strategic Analysis Review
QRxPharma Limited (QRxPharma) is clinical-stage specialty pharmaceutical company. The company is engaged in the development, manufacture and sale of products pertaining to pain management and central nervous system disorders therapy areas. Its products under investigation include MoxDuo CR, MoxDuo IR and MoxDuoIV. Its lead drug candidate MoxDuo IR is being developed in Phase III clinical trial for the treatment of acute management of moderate to severe pain. MoxDuoIV and MoxDuo CR are in Phase II and Phase I clinical trials respectively. In addition, the company investigating T9001, Haempatch and Textilinin in Pre clinical stage of development.
QRxPharma Limited Key Recent Developments
Apr 14, 2010: QRxPharma Completes Phase 3 Combination Rule Study Of MoxDuoIR
Mar 30, 2010: QRxPharma Begins MoxDuo CR Phase 1 Trial
Feb 24, 2010: QRxPharma, China Aoxing Enter Into Strategic Alliance For MoxDuo IV
Feb 23, 2010: QrxPharma And China Aoxing Partner For Development Of MoxDuoIV
Feb 10, 2010: QRxPharma Begins MoxDuoIR Second Phase 3 Trial
This comprehensive SWOT profile of QRxPharma Limited provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of QRxPharma Limited, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
